| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/15/1990 | US4925871 Antiulcer, capillary permeability, wound healing |
| 05/15/1990 | US4925870 Antiulcer and wound healing agents |
| 05/15/1990 | US4925869 Reactivating enzyme acetylcholinesterase inhibited by lethal dose of soman |
| 05/15/1990 | US4925867 Hydrocarbon substituted pyrrolidinones, intermediates therefor, and anti-convulsant use thereof |
| 05/15/1990 | US4925865 Antimycotic agents |
| 05/15/1990 | US4925863 1,3-di(1,2,4-triazol-1-yl)-2-propanol derivatives substituted with a styryl group |
| 05/15/1990 | US4925861 Leukotriene antagonists, phospholipase inhibitors |
| 05/15/1990 | US4925860 Anticonvulsants |
| 05/15/1990 | US4925859 Novel 4-hydroxy-3-pyridine-carboxamides useful for treating inflammation and rheumatism |
| 05/15/1990 | US4925858 Oxazole and thiazole derivatives and their use for treating disorders caused by malfunction of AcCh |
| 05/15/1990 | US4925857 Pyridinyl-1H-pyrazole-1-alkanamides as antiarrhythmic agents |
| 05/15/1990 | US4925855 Imidazole derivatives and antimycotics containing them |
| 05/15/1990 | US4925854 Benzimidazole derivatives |
| 05/15/1990 | US4925852 3-demethylmevalonic acid derivatives, and pharmaceutical products based on these compounds |
| 05/15/1990 | US4925850 Derivatives of 2-((4-piperidinyl)methyl)-1,2,3,4-tetrahydroisoquinoline, their preparation and their application in therapeutics |
| 05/15/1990 | US4925849 Pharmaceutically useful pyrazolopyridines |
| 05/15/1990 | US4925848 Derivative of codeine useful as an agonist and process for the preparation of it |
| 05/15/1990 | US4925847 6-thioxanthines |
| 05/15/1990 | US4925846 2-thiazolyl-imidazo[1,2,-a]pyrimidines |
| 05/15/1990 | US4925845 Hypotensive agents |
| 05/15/1990 | US4925844 Antagonizing the pharmacological effects of a benzodiazepine receptor agonist |
| 05/15/1990 | US4925843 Substituted on quinazoline, phthalazine or pyrido(2,3-d)pyrimidine moieties |
| 05/15/1990 | US4925838 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds |
| 05/15/1990 | US4925837 Synergistic combination of alpha-blocker and calcium antagonist; hypotensive agents |
| 05/15/1990 | US4925835 Aziridinyl putrescine containing compositions and their uses in treating prostate cancer |
| 05/15/1990 | US4925834 Fertility control, antitumor agents |
| 05/15/1990 | US4925833 Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| 05/15/1990 | US4925831 Aminoalkyl naphthalenediols as host resistance enhancers against viral infection |
| 05/15/1990 | US4925736 Dispersed in carrier vehicle capable of deep penetration of mammalian skin |
| 05/15/1990 | US4925692 Food composition containing a siloxane polymer and a particulate silica |
| 05/15/1990 | US4925678 Endothelial envelopment drug carriers |
| 05/15/1990 | US4925676 Extended release gemfibrozil composition |
| 05/15/1990 | US4925674 Amoxicillin microencapsulated granules |
| 05/15/1990 | US4925673 Delivery systems for pharmacological agents encapsulated with proteinoids |
| 05/15/1990 | US4925672 Products containing a calcium antagonist and a lipid-lowering agent |
| 05/15/1990 | US4925666 Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide |
| 05/15/1990 | US4925662 Antitumor agent bonded to human immunoglobulin |
| 05/15/1990 | US4925659 Cosmetic application of polysiloxanes containing a β-keto ester group and compositions employed |
| 05/15/1990 | US4925658 Treatment of dermatologic, rheumatic, respiratory, ophthalmologic disorders |
| 05/15/1990 | US4925653 Sunscreen composition containing polyisobutylene and its use for the protection of human epidermis against ultraviolet radiations |
| 05/15/1990 | US4925478 Plant safening agents |
| 05/15/1990 | US4924624 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof |
| 05/15/1990 | CA2002414A1 Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase |
| 05/15/1990 | CA1269110A1 Oxygenated-alkyl derivatives of glutamic and aspartic acids with antagonistic activity to bio-active polypeptides and a method for their preparation |
| 05/15/1990 | CA1269109A2 Erythro diols |
| 05/15/1990 | CA1269107A1 Process for preparing new hydroxy alkoxy 4- phenylpropylindole derivatives and the salts thereof |
| 05/15/1990 | CA1269104A1 Alkene, alkyne or cycloalkylene derivatives |
| 05/15/1990 | CA1269103A1 Pyrido[1,2-a]pyrimidine derivatives |
| 05/15/1990 | CA1269102A1 14,17.beta.-ETHANO-14.beta.-ESTRATRIENES AND ESTRATETRAENES, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
| 05/15/1990 | CA1269044A1 Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2'3'-dideoxyinosine, 2'3' - dideoxyguanosine, or 2'3' -dideoxyadenosine |
| 05/14/1990 | EP0345308A4 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells. |
| 05/14/1990 | EP0278002A4 1-thiocarbamoylmethylpyrrolidine-2-thione and method of obtaining it. |
| 05/14/1990 | CA2002931A1 Pyrazolopyrimidine type mevalonolactones |
| 05/14/1990 | CA2002853A1 Potent inducers of terminal differentiation and method of use thereof |
| 05/14/1990 | CA2002774A1 1-aminoalkyl-3-oxysubstituted-4-aryl-1,3,4,5-tetrahydro-2h- 1,3-benzodiazepine-2-ones, a process for their preparation and their use as medicaments |
| 05/14/1990 | CA2002716A1 Pyranylethyl-naphthalene derivatives |
| 05/14/1990 | CA2002715A1 Compositions for topical treatment of skin diseases |
| 05/14/1990 | CA2002596A1 Hydrates of b-lactam antibiotic |
| 05/14/1990 | CA2002415A1 Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| 05/12/1990 | CA2002732A1 Effervescent ibuprofen preparations |
| 05/11/1990 | CA2002692A1 14.alpha., 17.alpha.-ethanoestratrienes |
| 05/11/1990 | CA2001574A1 Pharmaceutical preparation for percutaneous administration containing bunazosin or its salts |
| 05/10/1990 | DE3837494A1 Pharmaceutical composition for controlling psoriasis vulgaris |
| 05/10/1990 | CA2002637A1 Use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c |
| 05/10/1990 | CA2002624A1 Chemical process for the preparation of imidazoquinoxalines and intermediates for use in the process |
| 05/10/1990 | CA2002617A1 Memory-enhancing compositions containing dioxopiperidine derivatives |
| 05/10/1990 | CA2002299A1 Compositions for the transdermal delivery of buprenorphine salts |
| 05/09/1990 | EP0367748A2 Novel antiviral compounds |
| 05/09/1990 | EP0367747A2 Dideoxy-L-arabinitol derivatives as antiviral compounds |
| 05/09/1990 | EP0367734A1 Energy substrate containing hydroxycarboxylic acid and a glycerol ester |
| 05/09/1990 | EP0367724A1 Improvements in or relating to organic compounds |
| 05/09/1990 | EP0367678A1 5,6-Dihydro 4H-1,3-oxa(or thia)zine derivatives, processes for their preparation and therapeutic agents containing them |
| 05/09/1990 | EP0367601A1 N-(N-succinyl-l-leucyl) agmatine, related compounds and use in pharmacology |
| 05/09/1990 | EP0367586A1 Primycin solutions |
| 05/09/1990 | EP0367576A2 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity |
| 05/09/1990 | EP0367554A2 Insulin binders and inhibitors of insulin binding |
| 05/09/1990 | EP0367538A2 Stabilized phytic acid compositions |
| 05/09/1990 | EP0367533A2 Method of treatment for interstitial cystitis |
| 05/09/1990 | EP0367509A2 Formulations |
| 05/09/1990 | EP0367502A1 Methods of synthesizing benign prostatic hypertrophic agents |
| 05/09/1990 | EP0367484A1 Carboxylic acid derivates |
| 05/09/1990 | EP0367449A1 Mixed chalcogenide pyrylium salts of a Lewis base |
| 05/09/1990 | EP0367431A1 Novel composition for skin penetration enhancement |
| 05/09/1990 | EP0367382A1 Compositions containing 2-(2,6-dichloro-3-methylphenylamino)-benzoic acid and their use in the treatment of destructive periodontitis |
| 05/09/1990 | EP0367223A2 Chelants possessing ortho ligating functionality and complexes thereof |
| 05/09/1990 | EP0367205A1 2-Aminocarboxylic acids and their derivatives, methods for their preparation and their use as pharmaceutical compositions |
| 05/09/1990 | EP0367189A2 Sugar phosphates and sulfonates of epipodophyllotoxin glucosides |
| 05/09/1990 | EP0367130A2 Pyrrolidine derivatives |
| 05/09/1990 | EP0367124A1 Penicillanic acid derivatives |
| 05/09/1990 | EP0367110A1 1,4-diazepine derivative and its pharmaceutical use |
| 05/09/1990 | EP0367103A1 Topical ointment |
| 05/09/1990 | EP0367069A2 Substituted bisazoles, process for their preparation and their use as therapeutic agents |
| 05/09/1990 | EP0367056A2 A granulating composition and method |
| 05/09/1990 | EP0367040A1 Compounds for the treatment of urinary incontinence |
| 05/09/1990 | EP0367036A2 Substituted 3-aminosydnonimines, process for their preparation and their use |
| 05/09/1990 | EP0367019A1 Pharmaceutical compositions containing nitroxyalkyl amine with an amide function, and method for the preparation of the compounds |
| 05/09/1990 | EP0366990A2 Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same |
| 05/09/1990 | EP0366973A1 New 4-substituted anthracyclinones and anthracycline glycosides and the process for preparing them |
| 05/09/1990 | EP0366868A1 Substained release pharmaceutical composition containing alginate |
| 05/09/1990 | EP0366753A1 N-alkoxyalkylamides and cosmetic treating compositions therewith |